Viewing Study NCT05659056


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-25 @ 9:25 PM
Study NCT ID: NCT05659056
Status: RECRUITING
Last Update Posted: 2024-04-16
First Post: 2022-12-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module